neurology
FDA Approves Aqneursa for Neurologic Symptoms of Niemann-Pick Disease Type C
The FDA approved Aqneursa for treating neurologic symptoms of Niemann-Pick disease type C in adults and pediatric ...
SEPTEMBER 26, 2024
Hard Conversations in Adolescent Epilepsy
Because of medication interactions, risks for abuse and the teratogenic effects of anti-seizure drugs, adolescents ...
FEBRUARY 21, 2024
Black Women With Hypertension Before Age 35 May Have Increased Stroke Risk
Black women who develop hypertension before 35 years of age that warrants an antihypertensive medication may have ...
FEBRUARY 12, 2024
FDA Approves Qulipta for Chronic Migraine
The FDA expanded the indication for Qulipta for the preventive treatment of migraine in adults.
APRIL 18, 2023
FDA Approves Skyclarys for Friedreich’s Ataxia
The FDA approved Skyclarys as the first treatment for Friedreich’s ataxia.
MARCH 1, 2023
